Business Issues/Benchmarks: Page 12

Supreme Court Allows Fired Truck Driver to Use Federal Racketeering Law to Sue Cannabis Company

In a 5-4 split, the U.S. justices ruled the driver, Douglas Horn, could bring a civil lawsuit against Medical Marijuana Inc. under the RICO Act.

Advanced Flower Capital Provides $14 Million Secured Credit Facility to Subsidiaries of Standard Wellness Holdings

The credit facility will support Standard Wellness’ continued growth in Missouri, Utah and Ohio.

Tilray Shifts Cultivation of Flagship Brand, Strain

The Canadian cannabis company is now cultivating Good Supply Jean Guy at its Masson-Angers facility in Québec.

Congress’ Harris Rider Starves DC’s Economy—Cannabis Could Save It (Opinion)

As Washington faces fiscal constraints, unlocking the district’s adult-use cannabis program from the federal rider would bolster revenue.

Florida Bill to Restrict, Regulate Hemp Products Advances to Senate Floor

The legislation would prohibit synthetic cannabinoids, require comprehensive testing and restrict where products can be sold.

Aurora Cannabis Recognized for Executive Gender Diversity

The Canadian cannabis company is an honoree in the Globe and Mail’s 2025 Report on Business magazine’s sixth annual Women Lead Here list.

Revisiting Gonzalez in the Face of a Potential Circuit Split

There are four active appeals challenging trial court decisions holding that the dormant Commerce Clause does not apply to state cannabis license preferences.

California Cannabis Operators Association Backs Bill to Halt Excise Tax Hike

The CaCOA urged the immediate passage of Assembly Bill 564, sponsored by Assembly Member Matt Haney.

California’s Top Cannabis Regulator Suggests Governor Has Little to Do With Tax Increase

Gov. Gavin Newsom proposed the state’s upcoming excise tax increase on cannabis sales in 2022 and signed legislation that ensued.

Maryland Governor, Legislative Leaders Agree on 33% Cannabis Tax Hike

Gov. Wes Moore hopes the budget agreement will generate $1 billion in new tax revenue, including roughly $39 million from the cannabis tax increase.

SNDL Reports Q4 and Full Year 2024 Financial and Operational Results

The company reported record full-year net revenue, gross profit and gross margin, as well as positive cash flow and free cash flow.

DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development

In ‘huge first,’ systemically absorbed oral cannabinoid AJA001 from Charlotte’s Web genetics receives FDA clearance for Phase 2 clinical trials.

Previous Page

Page 12 of 520

Next Page